US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B

US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B

Posted In: BriefsCOVID-19 CoronavirusBiotechGovernmentLong IdeasNewsHealth CareContractsMoversTrading IdeasGeneral